<DOC>
	<DOCNO>NCT01348074</DOCNO>
	<brief_summary>It know best restart warfarin temporary withdrawal . Participants randomize two group . Group 1 restart warfarin usual maintenance dose , group 2 restart warfarin double maintenance dose two day follow usual maintenance dose . The main outcome parameter number patient back therapeutic INR ( international normalize ratio ) range 4 , 9 day restart anticoagulation warfarin . Thromboembolic and/or bleed event record additional parameter . These data collect standardized telephone interview 1 month . In addition , investigator evaluate possible prothrombotic state measure potential thrombin generation D-dimers subset patient visit HHS-General Hospital INR test .</brief_summary>
	<brief_title>Reinitiation Anticoagulation After Temporary Withdrawal Vitamin K Antagonist</brief_title>
	<detailed_description>We investigate feasible use double maintenance dose first two administration vitamin K antagonist drug temporarily interrupt thus keep time increase risk thromboembolism duration `` bridging '' minimum . The control group consist patient resume vitamin K antagonists usual maintenance dose . The aim study establish best restart anticoagulation vitamin K antagonists temporal withdrawal drug . The main outcome parameter proportion patient back therapeutic international normalize ratio ( INR ) ratio certain day restart vitamin K antagonist . Two additional parameter evaluate : Firstly , bleed thromboembolic complication report secondly , possible prothrombotic state , measure elevation D-dimer , initiation anticoagulation evaluate .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Current treatment warfarin Need temporary interruption invasive procedure surgery Need postoperative hospitalization one day Participation another clinical trial No consent give</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>warfarin</keyword>
	<keyword>surgery</keyword>
	<keyword>management</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>bleeding</keyword>
</DOC>